Related Experiment Videos
Effect of low dose droperidol on postoperative vomiting in children
Insights
Low-dose droperidol effectively reduced postoperative vomiting in children aged 11-15 years. This study found no prolonged recovery or adverse effects, supporting its use for preventing nausea and vomiting in pediatric patients.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
Background:
- Postoperative vomiting (POV) is a common complication in children.
- Effective antiemetic strategies are crucial for pediatric surgical care.
Purpose of the Study:
- To evaluate the efficacy of low-dose droperidol in preventing postoperative vomiting in children.
- To assess the safety profile of low-dose droperidol in this population.
Main Methods:
- Double-blind, placebo-controlled study involving 200 children (1-15 years, ASA I-II).
- Administration of low-dose droperidol (0.005 mg x kg-1) before operation completion.
- Assessment of postoperative vomiting incidence and adverse events.
Main Results:
- Droperidol significantly reduced POV incidence in children aged 11-15 years.
- No increase in post-anaesthetic care unit (PACU) stay was observed.
- No extrapyramidal symptoms were reported.
Conclusions:
- Low-dose droperidol (0.005 mg x kg-1) is effective in preventing POV in older children (11-15 years).
- This prophylactic measure can be considered for pediatric patients at high risk for POV without compromising safety.
Abstract:
This double-blind study assessed the effect of low dose droperidol (0.005 mg x kg-1) on the incidence of postoperative vomiting in 200 children in ASA classification I and II, ranging from one to 15 years of age. The results showed that the dose of droperidol used in this study was very effective in reducing vomiting in children 11 to 15 years of age. The duration of stay in the post-anaesthetic care unit was not prolonged and no extrapyramidal symptoms related to the drug were observed. In our opinion the administration of droperidol 0.005 mg x kg-1 before the end of the operation will reduce the possibility of vomiting within 24 hours of operation in children in 11-15 year age group who are expected to have a high incidence of postoperative vomiting.